12:00 AM
Jan 02, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CPP-115: Phase Ia started

Catalyst began a double-blind, placebo-controlled, single ascending-dose U.S. Phase Ia trial to evaluate CPP-115 in about...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >